Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain

Virology

Volumn 290, Issue 1, 2001, Pages 59-73

  Stefano Cole, Kelly ^a   Alvarez, Martha ^b   Elliott, Debra H ^b   Lam, Hoa ^b   Martin, Effie ^b   Chau, Thao ^b   Micken, Katie ^b   Rowles, Jennifer L ^a   Clements, Janice E ^c   Murphey Corb, Michael ^a   Montelaro, Ronald C ^a   Robinson, James E ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; EPITOPE; MONOCLONAL ANTIBODY; RHESUS MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANTIBODY RESPONSE; ARTICLE; CARBOXY TERMINAL SEQUENCE; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; RELIABILITY; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MURINAE; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0035841649     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1144     Document Type: Article

References (68)

1. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells
2. Analysis of envelope changes acquired by SIVmac239 during neuroadaptation in rhesus macaques
3. Specificity of antipeptide antibodies produced against V2 and V3 regions of the external envelope of human immunodeficiency virus type 2
4. Specificity and neutralizing capacity of three monoclonal antibodies produced against the envelope glycoprotein of simian immunodeficiency virus isolate 251
5. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins
6. Transmissible lymphoma and simian acquired immunodeficiency syndrome in rhesus macaques
7. Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus
8. Characterization of B-cell epitopes in the envelope glycoproteins of simian immunodeficiency virus
9. Immunologic techniques for animal viruses
10. Effects of natural sequence variation of recognition by monoclonal antibodies that neutralize simian immunodeficiency virus infectivity
11. Cross-protective immune responses induced in rhesus macaques by immunization with an attenuated macrophage-tropic simian immunodeficiency virus
12. A model for the maturation of protective antibody responses to SIV envelope proteins in experimentally immunized monkeys
13. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with SIV and its association with the development of protective immunity
14. Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections
15. Maturation of antibody responses to linear SIV determinants
16. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques
17. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
18. An indicator cell assay for T-cell tropic, macrophage-tropic, and primary isolates of HIV-1 based on green fluorescent protein
19. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain
20. Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains
21. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein
22. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV
23. A general model for the surface glycoproteins of HIV and other retroviruses
24. Genetic typing of HIV-2 from a Senegalese/German heterosexual transmission
25. Passive immunization of rhesus macaques against SIV infection and disease
26. Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: Recovery from a long-term-nonprogressor SIV-infected macaque
27. Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp120 recognized by the human monoclonal antibody 1331A
28. Hypothetical assignment of intrachain disulfide bonds for HIV-2 and SIV envelope glycoproteins
29. The principal neutralizing determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus
30. Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein
31. Molecular clones of SIVsm and SIVagm: Experimental infection of macaques and African green monkeys
32. Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: Inverse relationship of degree of protection with level of attenuation
33. Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIVmac envelope glycoprotein
34. Beitrag zue kollektiven behandlung pharmakologischer reinhenversuche
35. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoprotein
36. Identification of two neutralizing and eight non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies
37. Characterization of neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies
38. Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251
39. B cell epitopes on the envelope glycoproteins of SIV and HIV-2
40. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus
41. Antigenic variation of SIV: Mutations in V4 alter the neutralization profile
42. Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus
43. Properties of virus-like particles produced by SIV chronically infected human cell clones
44. Molecular cloning of two West African human immunodeficiency virus type 2 isolates that replicate well in macrophages: A Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate
45. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells
46. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge
47. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac
48. Neutralizing monoclonal antibody against an external envelope glycoprotein (gp110) of SIVmac251
49. Comparison of serum antibody reactivities to a conformational and to linear antigenic sites in the external envelope glycoprotein of simian immunodeficiency virus (SIVmac) induced by infection and vaccination
50. Identification of broadly reactive continuous antigenic determinants of simian immunodeficiency virus glycoproteins
51. Maturation of immune responses to lentivirus infection: Implications for AIDS vaccine development
52. Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys
53. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: Persistent infection of rhesus monkeys with molecularly cloned SIVmac
54. The V3 domain of SIVmac251 gp120 contains a linear neutralizing epitope
55. Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma
56. A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin A
57. Identification of conserved and variant epitopes of human immunodeficiency virus type 1 (HIV-1) gp120 by human monoclonal antibodies produced by EBV-transformed cell lines
58. Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine
59. Identification of four antibody-binding sites in the envelope proteins of simian immunodeficiency virus, SIVsm
60. Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques
61. Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody
62. Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein
63. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
64. SIV envelope glycoprotein epitopes recognized by antibodies from infected or vaccinated rhesus macaques
65. An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation
66. Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection
67. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection
68. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus